Factors affecting the decision to initiate antiretroviral therapy in the era of treatment-as-prevention: synthesis of evidence from qualitative research in high-income settings
- 26 August 2018
- journal article
- research article
- Published by Taylor & Francis in AIDS Care
- Vol. 31 (4) , 397-402
Abstract
The emergence of treatment-as-prevention has made early initiation of antiretroviral treatment (ART) a “universal” policy. This review synthesizes qualitative research findings on barriers and facilitators of ART initiation in Organization for Economic Co-operation and Development (OECD) countries published since 2010. Ten articles describing seven research studies were included in the review. Findings confirmed ART initiation as a complicated process involving careful deliberation of the personal risks and benefits of treatment within the broader contexts of everyday life for people living with HIV (PLHIV). They also highlight interpersonal dynamics and concern for the public as increasingly important factors in shaping the decision to initiate treatment. The review provides valuable information for understanding treatment behaviour and maximizing treatment options brought forth by new biomedical advances.Keywords
This publication has 20 references indexed in Scilit:
- Factors associated with antiretroviral treatment uptake and adherence: a review. Perspectives from Australia, Canada, and the United KingdomAIDS Care, 2015
- Retained in HIV Care But Not on Antiretroviral Treatment: A Qualitative Patient-Provider Dyadic StudyPLOS Medicine, 2015
- Becoming “Undetectable”: Longitudinal Narratives of Gay Men's Sex Lives After a Recent HIV DiagnosisAIDS Education and Prevention, 2015
- Diagnostic Technologies in PracticeQualitative Health Research, 2014
- HIV Treatment As Prevention: How Scientific Discovery Occurred And Translated Rapidly Into Policy For The Global ResponseHealth Affairs, 2012
- Medication-Related Barriers to Entering HIV CareAIDS Patient Care and STDs, 2012
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine, 2011
- Individual Variability in Barriers Affecting People's Decision to Take HAART: A Qualitative Study Identifying Barriers to Being on HAARTAIDS Patient Care and STDs, 2006
- Pharmaceutical Citizenship: Antidepressant Marketing and the Promise of Demarginalization in IndiaAnthropology & Medicine, 2005
- "I will start treatment when I think the time is right": HIV-positive gay men talk about their decision not to access antiretroviral therapyAIDS Care, 2001